Thursday's Health Winners & Losers
Shares of
Cephalon
(CEPH)
were up 1.5% to $57.93 after investment bank Morgan Stanley initiated coverage of the stock.
Women's health care company
Novavax
(NVAX) - Get Novavax, Inc. Report
rose after the company named Jeffrey Church its new chief financial officer. Church was most recently CFO at GenVec. Novavax shares were up 4.8% to $3.27.
Genitope's
(GTOP)
shares sank 4.3% to $2.46 after the company discussed interim data on its MyVax personalized immunotherapy for previously untreated follicular lymphoma. According to a regulatory filing and a conference call, as of June 15, more than half of the patients in a late-phase MyVax clinical trial, or 158 of 287 patients, got worse.
Among other health stocks on the move were
Micromet
(MITI)
, down 6.3% to $2.53,
Illumina
TheStreet Recommends
(ILMN) - Get Illumina, Inc. Report
, falling 2.9% to $31.95,
Valera Pharmaceuticals
(VLRX) - Get Valeritas Holdings, Inc. Report
, 6.7% lower to $5.99,
Tapestry Pharmaceuticals
(TPPH)
, down 3.2% to $2.73, and
GlaxoSmithKline
(GSK) - Get GlaxoSmithKline Plc Report
, whose shares fell 1.1% to $55.02.
ImClone Systems
(IMCL)
gained 2.9% to $29.83,
Affymetrix
(AFFX)
was up 5.1% to $22.06,
Amgen
(AMGN) - Get Amgen Inc. Report
rose 0.8% to $67.12,
Dendreon
(DNDN)
advanced 2.6% to $4.38 and
Pharmion
(PHRM)
was up 7.9% to $18.09.
